NEW YORK (GenomeWeb) – NanoString Technologies and Cell Signaling Technology announced today that they are partnering to add CST's highly validated antibodies to NanoString's 3D Biology Protein Profiling Panels.

The companies plan to create new protein-based assays that will expand NanoString's 3D Biology product offerings. Under the terms of the deal, CST will supply antibodies for use in NanoString assays and NanoString will market and sell the assays for use with its nCounter Analysis System.

Further terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.

Sponsored by

This online, interactive seminar will answer researchers’ most pressing questions about how to gain outstanding research results from proteomic studies.